Last reviewed · How we verify

Calcifediol (Vitamin D)

Maimónides Biomedical Research Institute of Córdoba · FDA-approved active Small molecule

Calcifediol is an active form of vitamin D that binds to the vitamin D receptor to regulate calcium and phosphate homeostasis and modulate immune function.

Calcifediol is an active form of vitamin D that binds to the vitamin D receptor to regulate calcium and phosphate homeostasis and modulate immune function. Used for Vitamin D deficiency, Hypocalcemia, Secondary hyperparathyroidism.

At a glance

Generic nameCalcifediol (Vitamin D)
SponsorMaimónides Biomedical Research Institute of Córdoba
Drug classVitamin D analog
TargetVitamin D receptor (VDR)
ModalitySmall molecule
Therapeutic areaEndocrinology / Bone and Mineral Metabolism
PhaseFDA-approved

Mechanism of action

Calcifediol (1,25-dihydroxyvitamin D3) is the most biologically active metabolite of vitamin D. It acts as a ligand for the vitamin D receptor (VDR), a nuclear receptor that regulates gene expression involved in calcium absorption, bone metabolism, and immune cell differentiation. This mechanism makes it useful for treating vitamin D deficiency, hypocalcemia, and certain bone and mineral disorders.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results